ICU Medical, Inc.
ICUI
$140.19
-$1.40-0.99%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.14% | 6.47% | 8.58% | -0.35% | 1.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.14% | 6.47% | 8.58% | -0.35% | 1.70% |
| Cost of Revenue | -3.30% | 4.03% | 8.98% | 1.28% | 3.28% |
| Gross Profit | 32.45% | 11.38% | 7.85% | -3.54% | -1.92% |
| SG&A Expenses | 2.74% | 9.49% | 5.74% | 3.33% | 8.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.61% | 5.41% | 7.88% | 2.18% | 4.19% |
| Operating Income | 946.11% | 46.23% | 28.01% | -70.85% | -163.54% |
| Income Before Tax | 122.40% | -234.10% | 14.57% | -174.61% | -71.03% |
| Income Tax Expenses | 264.05% | 219.45% | 114.49% | 175.57% | -230.47% |
| Earnings from Continuing Operations | -38.96% | -555.69% | -115.48% | -302.27% | -10.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.96% | -555.69% | -115.48% | -302.27% | -10.37% |
| EBIT | 946.11% | 46.23% | 28.01% | -70.85% | -163.54% |
| EBITDA | 91.52% | 5.47% | 4.15% | -18.79% | -20.90% |
| EPS Basic | -36.97% | -550.05% | -112.68% | -298.83% | -9.66% |
| Normalized Basic EPS | 144.51% | 63.37% | 56.70% | -629.18% | -166.74% |
| EPS Diluted | -38.15% | -550.15% | -113.28% | -297.56% | -9.66% |
| Normalized Diluted EPS | 144.51% | 63.00% | 56.70% | -629.18% | -166.74% |
| Average Basic Shares Outstanding | 1.46% | 1.27% | 1.32% | 0.87% | 0.63% |
| Average Diluted Shares Outstanding | 1.46% | 0.29% | 1.32% | 0.87% | 0.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
